Lung cancer risk assessment could be improved over existing guidelines by a four-protein biomarker blood test.
A test that is able to detect trace levels of circulating tumor cells could help spot the early signs of treatment not working for advanced prostate cancer patients.
Find out the key features of the breast tumor microenvironment as well as putative predictive biomarkers established in other tumor types. Insights from both fields could guide future studies to enable personalized breast cancer immunotherapy.
What advancements have we witnessed in the field of immunotherapy for lung cancer and what does the future of this field look like? Find out in this article from Lung Cancer Management.
Discover an effective biomarker for improving the management of colorectal cancer patients by enhancing the efficiency of detection and efficacy of targeting treatment.
Over the past decade immunotherapy has revolutionized oncology, however, only a small percentage of patients currently benefit. Discover several of the hurdles that need to be tackled to make immunotherapy available to more cancer patients.
Discover the issues concerning tissue-biomarker development and the hurdles faced in reaching the goal of truly personalized medicine.
A prospective clinical study of the implications of IL-8 in the diagnosis, aggressiveness and prognosis of prostate cancer
In this research article from Future Science OA discover the implications of IL-8 in the diagnosis, aggressiveness and prognosis of prostate cancer.
Discover the importance of DNA methylation changes in the identification of potential biomarkers relevant for clinical follow-up and personalized medicine of chronic lymphocytic leukemia.
Evaluation of T1/T2 ratios in a pilot study as a potential biomarker of biopsy: proven benign and malignant breast lesions in correlation with histopathological disease stage
In this research article discover the potential role of quantitative MRI (qMRI) utilizing T1/T2 ratios to differentiate benign from malignant breast lesions.